Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections

被引：86

作者：

Iversen, Patrick L. ^{[1
]}

Warren, Travis K. ^{[2
]}

Wells, Jay B. ^{[2
]}

Garza, Nicole L. ^{[2
]}

Mourich, Dan V. ^{[1
]}

Welch, Lisa S. ^{[2
]}

Panchal, Rekha G. ^{[2
]}

Bavari, Sina ^{[2
]}

机构：

[1] Sarepta Therapeut, Bothell, WA 98021 USA

[2] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA

来源：

VIRUSES-BASEL | 2012年 / 4卷 / 11期

关键词：

Ebola; Marburg; Phosphorodiamidate Morpholino Oligomer; PMOplus; Therapeutic; Antiviral; PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS; ENTERICA SEROVAR TYPHIMURIUM; CELL-PENETRATING PEPTIDES; AMINO-ACID-COMPOSITION; ESCHERICHIA-COLI; ANTISENSE OLIGOMERS; NONHUMAN-PRIMATES; TISSUE-CULTURE; C-MYC; INHIBITION;

D O I：

10.3390/v4112806

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

There are no currently approved treatments for filovirus infections. In this study we report the discovery process which led to the development of antisense Phosphorodiamidate Morpholino Oligomers (PMOs) AVI-6002 (composed of AVI-7357 and AVI-7539) and AVI-6003 (composed of AVI-7287 and AVI-7288) targeting Ebola virus and Marburg virus respectively. The discovery process involved identification of optimal transcript binding sites for PMO based RNA-therapeutics followed by screening for effective viral gene target in mouse and guinea pig models utilizing adapted viral isolates. An evolution of chemical modifications were tested, beginning with simple Phosphorodiamidate Morpholino Oligomers (PMO) transitioning to cell penetrating peptide conjugated PMOs (PPMO) and ending with PMOplus containing a limited number of positively charged linkages in the PMO structure. The initial lead compounds were combinations of two agents targeting separate genes. In the final analysis, a single agent for treatment of each virus was selected, AVI-7537 targeting the VP24 gene of Ebola virus and AVI-7288 targeting NP of Marburg virus, and are now progressing into late stage clinical development as the optimal therapeutic candidates.

引用

收藏

页码：2806 / 2830

页数：25

相关论文

共 54 条

[41] Inhibition of vesivirus infections in mammalian tissue culture with antisense morpholino oligomers [J].

Stein, DA ;

Skilling, DE ;

Iversen, PL ;

Smith, AW .

ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2001, 11 (05) :317-325

[42] Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus [J].

Stein, David A. ;

Huang, Claire Y. -H. ;

Silengo, Shawn ;

Amantana, Adams ;

Crumley, Stacy ;

Blouch, Robert E. ;

Iversen, Patrick L. ;

Kinney, Richard M. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) :555-565

[43] A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus [J].

Stone, Jeffrey K. ;

Rijnbrand, Rene ;

Stein, David A. ;

Ma, Yinghong ;

Yang, Yan ;

Iversen, Patrick L. ;

Andino, Raul .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :1970-1981

[44] Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs [J].

Sullivan, Nancy J. ;

Geisbert, Thomas W. ;

Geisbert, Joan B. ;

Shedlock, Devon J. ;

Xu, Ling ;

Lamoreaux, Laurie ;

Custers, Jerome H. H. V. ;

Popernack, Paul M. ;

Yang, Zhi-Yong ;

Pau, Maria G. ;

Roederer, Mario ;

Koup, Richard A. ;

Goudsmit, Jaap ;

Jahrling, Peter B. ;

Nabel, Gary J. .

PLOS MEDICINE, 2006, 3 (06) :865-873

[45] Morpholino antisense oligomers: Design, preparation, and properties [J].

Summerton, J ;

Weller, D .

ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (03) :187-195

[46] Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection [J].

Swenson, Dana L. ;

Warfield, Kelly L. ;

Warren, Travis K. ;

Lovejoy, Candace ;

Hassinger, Jed N. ;

Ruthel, Gordon ;

Blouch, Robert E. ;

Moulton, Hong M. ;

Weller, Dwight D. ;

Iversen, Patrick L. ;

Bavari, Sina .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :2089-2099

[47] Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture [J].

Tilley, Lucas D. ;

Hine, Orion S. ;

Kellogg, Jill A. ;

Hassinger, Jed N. ;

Weller, Dwight D. ;

Iversen, Patrick L. ;

Geller, Bruce L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) :2789-2796

[48] Antisense peptide-phosphorodiamidate morpholino oligomer conjugate:: dose-response in mice infected with Escherichia coli [J].

Tilley, Lucas D. ;

Mellbye, Brett L. ;

Puckett, Susan E. ;

Iversen, Patrick. L. ;

Geller, Bruce L. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (01) :66-73

[49]

Warfield Kelly L., 2006, PLoS Pathogens, V2, P5

[50] Advanced antisense therapies for postexposure protection against lethal filovirus infections [J].

Warren, Travis K. ;

Warfield, Kelly L. ;

Wells, Jay ;

Swenson, Dana L. ;

Donner, Kelly S. ;

Van Tongeren, Sean A. ;

Garza, Nicole L. ;

Dong, Lian ;

Mourich, Dan V. ;

Crumley, Stacy ;

Nichols, Donald K. ;

Iversen, Patrick L. ;

Bavari, Sina .

NATURE MEDICINE, 2010, 16 (09) :991-994

← 1 2 3 4 5 6 →